Article

AMO introduces next-generation, one-piece IOL in the United States

Advanced Medical Optics (AMO) announced the U.S. introduction of its next-generation, one-piece IOL (Tecnis) with design enhancements that target zero spherical aberration and improve night-driving simulator performance, according to the company.

Advanced Medical Optics (AMO) announced the U.S. introduction of its next-generation, one-piece IOL (Tecnis) with design enhancements that target zero spherical aberration and improve night-driving simulator performance, according to the company.

A 360-degree edge design (ProTec, AMO) provides an uninterrupted barrier edge to minimize cell migration to the posterior capsule. Unlike first-generation, one-piece lenses, the new lens has no interruption at the haptic-optic junction, according to the company. The lens also features a frosted edge to minimize edge glare. In addition, three-point fixation (Tri-Fix, AMO) provides stability. Refraction stabilizes quickly after the implantation procedure.

Made from a hydrophobic acrylic material that blocks ultraviolet light, the lens transmits the blue light needed for improved scotopic vision and healthy circadian rhythms. The IOL's one-piece design and reduced center thickness enable simple implantation with bag-friendly coplanar delivery and gentle unfolding haptics, the company said.

The lens has been designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services.

For more information, visit AMO at booths 1328 and 1628.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.